Pancreatic Cancer Research

ResearcherNorth Sichuan Medical UniversityActive in the last 2 years

Gang Quan

Matched on ORCID iD 0000-0001-9234-7527; OpenAlex author ID A5010959633. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2022: 2 papers · 2023: 2 papers · 2024: none · 2025: none · 2026: 2 papers

Papers 6

  1. Investigation of a GPC1-targeted and LIFU-responsive nanoplatform with ADV effect for visualized chemo-sonodynamic therapy against pancreatic ductal adenocarci… First author DOI 10.1007/s00432-026-06518-5↗
  2. A GPC1-Targeting multifunctional nanoplatform combining paclitaxel-mediated chemotherapy and chlorin e6-assisted sonodynamic therapy for Pancreatic Ductal Aden… Co-author DOI 10.1016/j.ctarc.2026.101139↗
  3. KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer. Co-author DOI 10.1038/s41419-023-05679-2↗
  4. VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation. First author DOI 10.1186/s12964-023-01209-x↗
  5. LINC00941 promotes pancreatic cancer malignancy by interacting with ANXA2 and suppressing NEDD4L-mediated degradation of ANXA2. Co-author DOI 10.1038/s41419-022-05172-2↗
  6. Hypoxia-Induced miR-210 Promotes Endothelial Cell Permeability and Angiogenesis via Exosomes in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2022/7752277↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianxin Jiang · 3 shared papers, 2022–2023 · strength 0.66
  2. Bo Ren · 2 shared papers, 2026 · strength 0.58
  3. Jichuan Xu · 2 shared papers, 2023 · strength 0.48
  4. Xinyuan Liu · 2 shared papers, 2022–2023 · strength 0.39
  5. Charng Choon Wong · 1 shared paper, 2026 · strength 0.30
  6. Jingdong Li · 1 shared paper, 2026 · strength 0.30
  7. Wong Charng Choon · 1 shared paper, 2026 · strength 0.28
  8. Jie Wang · 1 shared paper, 2023 · strength 0.22
  9. Yaqin Wang · 1 shared paper, 2022 · strength 0.17
  10. Zhiwei He · 1 shared paper, 2022 · strength 0.17
  11. Xueyi Jiang · 1 shared paper, 2022 · strength 0.17
  12. Jie Wang · 1 shared paper, 2022 · strength 0.17
  13. Jian Xu · 1 shared paper, 2022 · strength 0.17
  14. Guo Wu · 1 shared paper, 2022 · strength 0.17
  15. Zhonghu Li · 1 shared paper, 2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.